Overview
The Lipid Research Division is a division of the American Society for Biochemistry and Molecular Biology. The LRD represents lipid research scientists of the society and addresses concerns that include, but are not limited to, national and international visibility, representation at the annual meeting and on scientific advisory panels, and increased funding for lipid research. Additionally, the LRD serves as a platform within the ASBMB to highlight progress in lipid research and to foster communication among lipid researchers and between lipid researchers and the broader ASBMB membership.
We invite all lipid researchers to join the division. ASBMB membership is required.
Activities
- Provides input to the ASBMB Meetings Committee relating to symposia, themes and sessions at the society's annual meeting.
- Provides a calendar of lipid-related meetings, a job board and links to resources for lipid researchers.
- Presents the Walter Shaw Young Investigator Award in Lipid Research, which the division established, at the society's annual meeting.
- Works closely with National Institutes of Health scientific review officers to increase representation of lipid researchers on appropriate study sections.
- Hosts monthly webinars that feature and attract lipid researchers from around the world.
- Publishes the "Lipid News" column in ASBMB Today and maintains an active presence on Facebook and Twitter.
- Collaborates with the European-based Lipid Maps organization to publish "Lipid Trends."
- Publicizes lipid research articles from the Journal of Lipid Research and the Journal of Biological Chemistry.
Researchers in Australia have identified circular peptides, called cyclotides, that affect the formation of cell membranes, causing death or restricted growth.
Researchers at New York University have found that this long-lived phospholipid may underlie the insect’s extraordinary wing strength.
A gene that decreases disease progression in mice provides a new direction for human therapy.
A “T” makes a difference in blood clotting. High cholesterol: two screens are better than one. Biomarkers for cardiovascular risk. Statin-induced changes to the HDL lipidome. Read about recent papers on these topics.
Highlights
